DGAP-News: UMS AG announces key financial data for 2011 - Management Board and Supervisory Board propose dividend of EUR0.50 per share - Forecast for 2012 is EUR0.60 to EUR0.70 per share


DGAP-News: UMS United Medical Systems International AG / Key word(s):
Final Results/Dividend
UMS AG announces key financial data for 2011 - Management Board and
Supervisory Board propose dividend of EUR0.50 per share - Forecast for
2012 is EUR0.60 to EUR0.70 per share

27.03.2012 / 10:44

---------------------------------------------------------------------

UMS AG announces key financial data for 2011 - Management Board and
Supervisory Board propose dividend of EUR0.50 per share - Forecast for 2012
is EUR0.60 to EUR0.70 per share

Hamburg, 27 March 2012 - UMS United Medical Systems International AG (UMS/
ISIN DE0005493654) today released its key financial data for the 2011
fiscal year. The Company, which offers mobile service solutions for
selected fields of medicine, generated earnings per share in the amount of
EUR0.47 (2010: EUR0.61). This lies within the adjusted bandwidth of EUR0.45
to EUR0.55 per share that was announced last August.

As previously announced, UMS AG expects to maintain its dividend policy for
2011. Management Board and the Supervisory Board therefore plan to propose
to the shareholders' meeting on May 31, 2012 to again distribute a dividend
of EUR0.50 per share as in the previous year. This dividend will be paid
from the company's capital contributions account for tax purposes.

According to IFRS figures, the UMS Group's revenues amounted to EUR38.3
million in fiscal 2011, as opposed to EUR38.9 million in the previous year.
However, if exchange rate effects are ignored, revenues grew by EUR1.5
million, or 4%.

Group EBIT for 2011 amounted to EUR11.6 million, as compared to EUR12.8
million in the previous year. Consolidated net income for 2011 amounted to
EUR9.2 million, of which EUR2.3 million was attributable to the Group's
shareholders (2010: EUR3.1 million).

Jorgen Madsen, the CEO of UMS AG, explains: 'Particularly in the first half
of 2011, two factors temporarily had an adverse effect on our earnings: the
acquisition of a competitor and the start-up phase of additional equipment
capacities in the radiology sector. In the meantime, we have almost fully
booked the additional capacities and successfully completed the integration
of the acquired competitor. This makes us confident that we will see
revenue and earnings growth in the current fiscal year.'

UMS expects revenue growth to continue in fiscal year 2012 and thus expects
consolidated revenues between EUR41 million and EUR43 million. UMS expects
earnings per share to increase significantly in 2012, to between EUR0.60 to
EUR0.70.

UMS will publish the complete audited financial statements for fiscal year
2011 on April 3, 2012.

About UMS AG

UMS International AG is a provider of innovative healthcare delivery
concepts in the growth segment of high-tech medicine. UMS pioneered the
mobile deployment of high-class medical systems and markets a comprehensive
range of full-service solutions for hospitals and specialist physicians.
The forward-looking concepts include complete services for the customer,
covering everything from system management to the provision of trained
application specialists. The UMS Group currently has over 220 employees
worldwide and serves over 650 customers.

Contact:

Christian Möller, Tel: (040) 500 177-00, Fax: (040) 500 177-77, E-Mail:
investor@umsag.com


End of Corporate News

---------------------------------------------------------------------

27.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                               
Company:     UMS United Medical Systems International AG           
             Borsteler Chaussee 53                                 
             22453 Hamburg                                         
             Germany                                               
Phone:       +49 (0)40 - 500 177 - 00                              
Fax:         +49 (0)40 - 500 177 - 77                              
E-mail:      investor@umsag.com                                    
Internet:    www.umsag.com                                         
ISIN:        DE0005493654                                          
WKN:         549365                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
             Stuttgart                                             
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
162419 27.03.2012